Report of the RDAF Multi-Stakeholder Workshop on Registries for Rare Diseases

    14 Jul, 2021

    The Rare Disease Action Forum (RDAF) published the report about its multi-stakeholder workshop on ‘Registries for rare diseases in Switzerland’ which took place on 30 June 2021. The report provides an overview of the expert presentations and summarizes the exchanges within the roundtable discussion on disease specific registries. Representatives from patient organizations and industry, a healthcare professional, a legal expert and a member of the Swiss Parliament presented complementary perspectives on the current situation, the challenges and opportunities related to registries for rare diseases in Switzerland. They also outlined perspectives for the future development and called for unified action with the aim of fostering research and therapy development and increasing patients’ access to diagnosis, treatment and care. The full report is available here.

    The next workshop of the RDAF will take place in autumn and will focus on market access. More information will be available in due time.

    Continue reading

    Ipsen joins the Rare Disease Action Forum

    We are proud to welcome Ipsen as the newest member of the Rare Disease Action Forum. Reinforcing RDAF’s multi-stakeholder approach, they will be joining our other members including industry, patient organizations, healthcare professionals, and research organizations....

    UCB Pharma and HOPOS join the Rare Disease Action Forum

    We are proud to welcome UCB Pharma and HOPOS as the newest members of the Rare Disease Action Forum. Reinforcing RDAF’s multi-stakeholder approach, they will be joining our other members including industry, patient organizations, healthcare professionals, and research...